Tissue-engineered small intestine improves recovery after massive small bowel resection

Area of Science:

• Regenerative Medicine
• Gastroenterology
• Surgical Innovation

Background:

• Short bowel syndrome (SBS) is a severe complication following massive small bowel resection (MSBR).
• Tissue engineering offers a novel approach to organ replacement, with tissue-engineered small intestine (TESI) showing promise for SBS treatment.

Purpose of the Study:

• To evaluate the efficacy of TESI as a rescue therapy after MSBR in a rat model.
• To assess the impact of TESI implantation on weight recovery, nutrient absorption, and intestinal tissue characteristics.

Main Methods:

• Ten Lewis rats received TESI implantation using green fluorescent protein (GFP)-marked cells or underwent sham surgery, followed by MSBR.
• TESI was anastomosed to the proximal small intestine, and animal weights, transit times, and various tissue markers were analyzed post-surgery.
• Histological and molecular analyses, including immunohistochemistry and Northern blots, were performed to assess tissue integration and function.

Main Results:

• Rats receiving TESI showed significantly improved weight regain (98% of preoperative weight) compared to controls (76%) by day 40.
• Vitamin B12 absorption was markedly higher in the TESI group, indicating enhanced intestinal function.
• Histological analysis confirmed appropriate tissue architecture, presence of nerves, and persistence of GFP labeling in the engineered intestine.

Conclusions:

• Anastomosis of TESI significantly improved postoperative weight and vitamin B12 absorption in rats following MSBR.
• The presence of intestinal alkaline phosphatase (IAP) mRNA in TESI suggests epithelial differentiation, and successful GFP labeling was achieved.